https://www.marketscreener.com/quote/stock/MALIN-CORPORATION-PLC-21309480/news/Malin-Kymab-successor-company-Sanofi-announces-positive-topline-Phase-2b-data-in-atopic-dermatit-44202776/?utm_source=telegram&utm_medium=social&utm_campaign=share